#STEMCELL Mesenchymal Stem Cell‐Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise https://t.co/ywS5bAIUJ1
Concise Review: Mesenchymal Stem Cell-Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Sep 2020 – Nov 2023Where it's discussed
-
YouTube3 videos
-
Facebook3 posts
-
X / Twitter2 posts
-
Reddit2 posts
-
News2 articles
AI synopsis
What people are saying
The discussions reveal a nuanced view, highlighting both the potential benefits and hurdles of MSC-based delivery, with phrases like 'promising strategy' and 'challenges remain' illustrating balanced perspectives that stimulate academic curiosity and discourse on future improvements for targeted therapies.
Most discussions acknowledge the promising aspects of MSC-based drug delivery but also recognize its current technical challenges.
Participants show high curiosity about the mechanisms and improvements in targeting, indicating strong interest.
Comments reflect a moderate level of depth, such as references to specific homing mechanisms and tracking techniques.
The discussions suggest the article influences ongoing research efforts and highlights important challenges, although the influence is primarily academic.
Abstract in brief
- MSC-based drug delivery has great potential for treating diseases like cancer, but challenges remain in ensuring these cells target tumors effectively without harming other tissues.
- Current efforts include developing synthetic engineering methods to improve MSCs' ability to specifically home to tumors, some of which are already in clinical trials.
- However, progress is hindered by the lack of standardized, sensitive techniques for tracking and measuring MSC distribution and targeting efficiency in vivo.
Top posts
Most liked on X and Blueskyhttps://t.co/vWdj5Zyfht We provide a concise review of active and passive MSC homing mechanisms and biodistribution postinfusion; in addition to in vivo cell tracking methodologies and strategies to enhance tumor targeting with a focus on MSC-based drug delivery strategies.
All mentions
Mesenchymal Stem Cell Drug Delivery: Challenges and Opportunities
Mesenchymal stem cell-based drug delivery has great potential for treating diseases like cancer, but challenges remain in ensuring these cells target tumors effectively without harming other tissues. Current efforts are…
Mesenchymal Stem Cell Drug Delivery: Challenges and Future Prospects
MSC-based drug delivery offers potential for disease treatment, but faces challenges in targeting tumors effectively while avoiding harm to other tissues. Current strategies involve engineering MSCs for better homing…
Mesenchymal Stem Cell Drug Delivery: Benefits, Challenges, and Future Prospects
MSC-based drug delivery has great potential for treating diseases like cancer, but challenges remain in ensuring these cells target tumors effectively without harming other tissues. Current efforts include developing…
https://t.co/vWdj5Zyfht We provide a concise review of active and passive MSC homing mechanisms and biodistribution postinfusion; in addition to in vivo cell tracking methodologies and strategies to enhance tumor targeting with a focus on MSC-based drug delivery strategies.
#STEMCELL Mesenchymal Stem Cell‐Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise https://t.co/ywS5bAIUJ1